Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis.

Nizri E, Fiore M, Barretta F, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Stacchiotti S, Casali PG, Miceli R, Gronchi A.

Ann Surg Oncol. 2019 Jul 16. doi: 10.1245/s10434-019-07615-1. [Epub ahead of print]

PMID:
31313035
2.

Outcome of iliocaval resection and reconstruction for retroperitoneal sarcoma.

Ferraris M, Callegaro D, Barretta F, Fiore M, Radaelli S, Stacchiotti S, Miceli R, Socrate AM, Locati P, Gronchi A.

J Vasc Surg Venous Lymphat Disord. 2019 Jul;7(4):547-556. doi: 10.1016/j.jvsv.2018.10.023. Epub 2019 Feb 18.

PMID:
30792153
3.

Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.

Raut CP, Callegaro D, Miceli R, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria S, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Fiore M, Fairweather M, Gronchi A.

Clin Cancer Res. 2019 Apr 15;25(8):2664-2671. doi: 10.1158/1078-0432.CCR-18-2700. Epub 2019 Feb 5.

PMID:
30723141
4.

Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.

Haas RLM, Bonvalot S, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Gladdy R, Jakob J, Szacht M, Fiore M, Chung PW, van Houdt WJ, Raut CP, Gronchi A.

Cancer. 2019 Apr 15;125(8):1290-1300. doi: 10.1002/cncr.31927. Epub 2019 Jan 2.

5.

Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysis.

Nizri E, Fiore M, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Morosi C, Stacchiotti S, Casali PG, Gronchi A.

J Surg Oncol. 2019 Mar;119(3):318-323. doi: 10.1002/jso.25337. Epub 2018 Dec 16.

PMID:
30554403
6.

Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.

Oliveira LM, Apóstolos-Pereira SL, Pitombeira MS, Bruel Torretta PH, Callegaro D, Sato DK.

Mult Scler. 2018 Nov 12:1352458518811597. doi: 10.1177/1352458518811597. [Epub ahead of print]

PMID:
30417715
7.

Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.

Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, Griffin A, Hayes AJ, Stacchiotti S, Le Pèchoux C, Smith MJ, Fiore M, Dei Tos AP, Smith HG, Catton C, Casali PG, Wunder JS, Gronchi A.

Eur J Cancer. 2018 Dec;105:19-27. doi: 10.1016/j.ejca.2018.09.028. Epub 2018 Oct 29.

PMID:
30384013
8.

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.

Marques VD, Passos GRD, Mendes MF, Callegaro D, Lana-Peixoto MA, Comini-Frota ER, Vasconcelos CCF, Sato DK, Ferreira MLB, Parolin MKF, Damasceno A, Grzesiuk AK, Muniz A, Matta APDC, Oliveira BES, Tauil CB, Maciel DRK, Diniz DS, Corrêa EC, Coronetti F, Jorge FMH, Sato HK, Gonçalves MVM, Sousa NAC, Nascimento OJM, Gama PDD, Domingues R, Simm RF, Thomaz RB, Morales RR, Dias RM, Apóstolos-Pereira SD, Machado SCN, Junqueira TF, Becker J.

Arq Neuropsiquiatr. 2018 Aug;76(8):539-554. doi: 10.1590/0004-282X20180078.

9.

Staging, nomograms and other predictive tools in retroperitoneal soft tissue sarcoma.

Tattersall HL, Callegaro D, Ford SJ, Gronchi A.

Chin Clin Oncol. 2018 Aug;7(4):36. doi: 10.21037/cco.2018.08.01. Review.

10.

Pearls & Oy-sters: A curable myopathy manifesting as exercise intolerance and respiratory failure.

Silva AMS, Mendonça RH, Soares DC, Callegaro D, Caldas VM, Perissinotti IN, Carvalho MS, Zanoteli E.

Neurology. 2018 Jul 24;91(4):187-190. doi: 10.1212/WNL.0000000000005867. No abstract available.

PMID:
30037914
11.

Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis.

Boa INF, Rimkus CM, Campanholo KR, Pereira SLA, Junqueira TF, Machado MAR, Callegaro D, Otaduy MCG, Leite CDC, Miotto EC.

Arq Neuropsiquiatr. 2018 May;76(5):302-309. doi: 10.1590/0004-282X20180038.

12.

Consistent Margin-Status Reporting in Soft Tissue Sarcoma Is Essential to Establish Risk-Adapted Strategies Integrating Biology and Histotype in Perioperative Treatments.

Levy A, Bonvalot S, Callegaro D, Botticella A, Le Cesne A, Gronchi A, Le Péchoux C.

J Clin Oncol. 2018 Aug 1;36(22):2357-2358. doi: 10.1200/JCO.2018.78.6657. Epub 2018 Jun 7. No abstract available.

PMID:
29878864
13.

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.

Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, Tanaka S, Nomura K, Hashimoto Y, Callegaro D, Steinman L, Fujihara K, Aoki M.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):927-936. doi: 10.1136/jnnp-2018-317969. Epub 2018 Jun 6. Erratum in: J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):e4.

14.

Normative values of the Brief Repeatable Battery of Neuropsychological Tests in a Brazilian population sample: discrete and regression-based norms.

Damasceno A, Amaral JMSDS, Barreira AA, Becker J, Callegaro D, Campanholo KR, Damasceno LA, Diniz DS, Fragoso YD, Franco PS, Finkelsztejn A, Jorge FMH, Lana-Peixoto MA, Matta APDC, Mendonça ACR, Noal J, Paes RA, Papais-Alvarenga RM, Pereira AG, Spedo CT, Damasceno BP.

Arq Neuropsiquiatr. 2018 Mar;76(3):163-169. doi: 10.1590/0004-282x20180006.

15.

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.

Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK.

Front Neurol. 2018 Apr 4;9:217. doi: 10.3389/fneur.2018.00217. eCollection 2018. Review.

16.

The protective effects of high-education levels on cognition in different stages of multiple sclerosis.

Rimkus CM, Avolio IMB, Miotto EC, Pereira SA, Mendes MF, Callegaro D, Leite CDC.

Mult Scler Relat Disord. 2018 May;22:41-48. doi: 10.1016/j.msard.2018.03.001. Epub 2018 Mar 6.

PMID:
29554549
17.

High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.

Pasquali S, Colombo C, Pizzamiglio S, Verderio P, Callegaro D, Stacchiotti S, Martin Broto J, Lopez-Pousa A, Ferrari S, Poveda A, De Paoli A, Quagliuolo V, Jurado JC, Comandone A, Grignani G, De Sanctis R, Palassini E, Llomboart-Bosch A, Dei Tos AP, Casali PG, Picci P, Gronchi A.

Eur J Cancer. 2018 Apr;93:28-36. doi: 10.1016/j.ejca.2018.01.071. Epub 2018 Feb 21.

PMID:
29475197
18.

Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard?

Fiore M, Ford S, Callegaro D, Sangalli C, Colombo C, Radaelli S, Frezza AM, Renne SL, Casali PG, Gronchi A.

Ann Surg Oncol. 2018 Jun;25(6):1536-1543. doi: 10.1245/s10434-018-6393-x. Epub 2018 Feb 22.

PMID:
29470819
19.

Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma.

Tseng WW, Tsao-Wei DD, Callegaro D, Grignani G, D'Ambrosio L, Bonvalot S, Ethun CG, Cardona K, Mullen JT, Canter RJ, Mullinax JE, Gonzalez RJ, van Coevorden F, Albertsmeier M, Dhanireddy KK, Renne SL, Gronchi A; A Collaborative Effort from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG).

Eur J Surg Oncol. 2018 Jun;44(6):810-815. doi: 10.1016/j.ejso.2018.01.086. Epub 2018 Feb 5.

PMID:
29452860
20.

Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor.

Provenzano S, Raimondi A, Bertulli RM, Colia V, Renne SL, Collini P, Dagrada G, Callegaro D, Fiore M, Greco FG, Casali PG.

Clin Sarcoma Res. 2017 Dec 28;7:20. doi: 10.1186/s13569-017-0086-2. eCollection 2017.

21.

Prognostic models for RPS patients-Attempting to predict patient outcomes.

Callegaro D, Miceli R, Gladdy RA.

J Surg Oncol. 2018 Jan;117(1):69-78. doi: 10.1002/jso.24903. Epub 2017 Dec 19. Review.

PMID:
29266220
22.

A severe phenotype of Kennedy disease associated with a very large CAG repeat expansion.

Madeira JLO, Souza ABC, Cunha FS, Batista RL, Gomes NL, Rodrigues AS, Mennucci de Haidar Jorge F, Chadi G, Callegaro D, Mendonca BB, Costa EMF, Domenice S.

Muscle Nerve. 2018 Jan;57(1):E95-E97. doi: 10.1002/mus.25952. Epub 2017 Sep 18. No abstract available.

PMID:
28877561
23.

Beyond weakness: Characterization of pain, sensory profile and conditioned pain modulation in patients with motor neuron disease: A controlled study.

Lopes LCG, Galhardoni R, Silva V, Jorge FMH, Yeng LT, Callegaro D, Chadi G, Teixeira MJ, Ciampi de Andrade D.

Eur J Pain. 2018 Jan;22(1):72-83. doi: 10.1002/ejp.1091. Epub 2017 Aug 22.

PMID:
28833988
24.

Sarcoma nomograms: a light over the darkness.

Callegaro D, Miceli R, Gronchi A.

Oncoscience. 2017 Mar 16;4(3-4):15-16. doi: 10.18632/oncoscience.341. eCollection 2017 Mar. No abstract available.

25.

Soft tissue sarcoma nomograms and their incorporation into practice.

Callegaro D, Miceli R, Mariani L, Raut CP, Gronchi A.

Cancer. 2017 Aug 1;123(15):2802-2820. doi: 10.1002/cncr.30721. Epub 2017 May 10. Review.

26.

Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.

MacNeill AJ, Gronchi A, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Barretta F, Raut CP, Strauss DC.

Ann Surg. 2018 May;267(5):959-964. doi: 10.1097/SLA.0000000000002250.

PMID:
28394870
27.

Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.

MacNeill AJ, Miceli R, Strauss DC, Bonvalot S, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP, Gronchi A, Swallow CJ.

Cancer. 2017 Jun 1;123(11):1971-1978. doi: 10.1002/cncr.30572. Epub 2017 Feb 2.

28.

Renal angiomyolipomas: At least two diseases. A series of patients treated at two European institutions.

Delhorme JB, Fontana A, Levy A, Terrier P, Fiore M, Tzanis D, Callegaro D, Dratwa C, Gronchi A, Bonvalot S.

Eur J Surg Oncol. 2017 Apr;43(4):831-836. doi: 10.1016/j.ejso.2016.11.012. Epub 2016 Dec 5.

PMID:
28007324
29.

Genetic analysis of patients with familial and sporadic amyotrophic lateral sclerosis in a Brazilian Research Center.

Chadi G, Maximino JR, Jorge FMH, Borba FC, Gilio JM, Callegaro D, Lopes CG, Santos SND, Rebelo GNS.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):249-255. doi: 10.1080/21678421.2016.1254245. Epub 2016 Dec 15.

PMID:
27978769
30.

Anti-MOG (Myelin Oligodendrocyte Glycoprotein)-Positive Severe Optic Neuritis with Optic Disc Ischaemia and Macular Star.

Moura FC, Sato DK, Rimkus CM, Apóstolos-Pereira SL, de Oliveira LM, Leite CC, Fujihara K, Monteiro ML, Callegaro D.

Neuroophthalmology. 2015 Nov 10;39(6):285-288. eCollection 2015 Dec.

31.

Polyomavirus detection in multiple sclerosis patients under natalizumab therapy: Profile and frequency of urinary shedding.

Nali LH, Fink MC, do Olival GS, Moraes L, Callegaro D, Tilbery CP, Vidal JE, Sumita LM, de Oliveira AC, Romano CM.

J Med Virol. 2017 Mar;89(3):528-534. doi: 10.1002/jmv.24646. Epub 2016 Aug 9.

PMID:
27464945
32.

Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.

Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, Griffin A, Hayes AJ, Stacchiotti S, Pechoux CL, Smith MJ, Fiore M, Dei Tos AP, Smith HG, Mariani L, Wunder JS, Pollock RE, Casali PG, Gronchi A.

Lancet Oncol. 2016 May;17(5):671-80. doi: 10.1016/S1470-2045(16)00010-3. Epub 2016 Apr 5.

PMID:
27068860
33.

Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.

da Silva NL, Takemoto MLS, Damasceno A, Fragoso YD, Finkelsztejn A, Becker J, Gonçalves MVM, Tilbery C, de Oliveira EML, Callegaro D, Boulos FC.

BMC Health Serv Res. 2016 Mar 24;16:102. doi: 10.1186/s12913-016-1352-3.

34.

Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.

Becker J, Callegaro D, Lana-Peixoto MA, Talim N, Vidaletti T, de Paula Corrêa M, Gomes I.

J Neurol Sci. 2016 Apr 15;363:236-9. doi: 10.1016/j.jns.2016.02.064. Epub 2016 Feb 27.

PMID:
27000256
35.

A disturbed processing of graviceptive pathways may be involved in the pathophysiology of balance disorders in patients with multiple sclerosis.

da Fonseca BA, Pereira CB, Jorge F, Simm R, Apostolos-Pereira S, Callegaro D.

Arq Neuropsiquiatr. 2016 Feb;74(2):106-11. doi: 10.1590/0004-282X20160004.

36.

Resectable extra-pleural and extra-meningeal solitary fibrous tumours: A multi-centre prognostic study.

Pasquali S, Gronchi A, Strauss D, Bonvalot S, Jeys L, Stacchiotti S, Hayes A, Honore C, Collini P, Renne SL, Alexander N, Grimer RJ, Callegaro D, Sumathi VP, Gourevitch D, Desai A.

Eur J Surg Oncol. 2016 Jul;42(7):1064-70. doi: 10.1016/j.ejso.2016.01.023. Epub 2016 Feb 13.

PMID:
26924782
37.

External validation of a multi-institutional retroperitoneal sarcoma nomogram.

Raut CP, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Fiore M, Callegaro D, Casali PG, Haas RL, Hayes AJ, Honore C, Cannell AJ, Jakob J, Szacht M, Fairweather M, Pollock RE, Bonvalot S, Gronchi A.

Cancer. 2016 May 1;122(9):1417-24. doi: 10.1002/cncr.29931. Epub 2016 Feb 24.

38.

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.

Kaneko K, Sato DK, Nakashima I, Nishiyama S, Tanaka S, Marignier R, Hyun JW, Oliveira LM, Reindl M, Seifert-Held T, Sepulveda M, Siritho S, Waters PJ, Kurosawa K, Akaishi T, Kuroda H, Misu T, Prayoonwiwat N, Berger T, Saiz A, Kim HJ, Nomura K, Callegaro D, Fujihara K, Aoki M.

J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1257-1259. doi: 10.1136/jnnp-2015-312676. Epub 2016 Jan 22. No abstract available.

PMID:
26800711
39.

Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.

Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Cannell A, Jakob J, Haas RL, Szacht M, Fiore M, Casali PG, Pollock RE, Raut CP.

Ann Surg. 2016 May;263(5):1002-9. doi: 10.1097/SLA.0000000000001447.

PMID:
26727100
40.

Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.

Fiore M, Colombo C, Radaelli S, Callegaro D, Palassini E, Barisella M, Morosi C, Baldi GG, Stacchiotti S, Casali PG, Gronchi A.

Eur J Cancer. 2015 Dec;51(18):2800-7. doi: 10.1016/j.ejca.2015.08.026. Epub 2015 Nov 18.

PMID:
26602014
41.

Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.

Oliveira EM, Simm RF, Dasic G, Morais MM, Perreira SL, Callegaro D.

Arq Neuropsiquiatr. 2015 Sep;73(9):736-40. doi: 10.1590/0004-282X20150098.

42.

Leukoencephalopathy resolution after atypical mycobacterial treatment: a case report.

Oliveira MC, Sato DK, Soares-Neto HR, Lucato LT, Callegaro D, Nitrini R, Medeiros RS, Misu T, Fujihara K, Castro LH.

BMC Neurol. 2015 Sep 2;15:159. doi: 10.1186/s12883-015-0415-0.

43.

Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.

Alves CJ, Dariolli R, Jorge FM, Monteiro MR, Maximino JR, Martins RS, Strauss BE, Krieger JE, Callegaro D, Chadi G.

Front Cell Neurosci. 2015 Aug 4;9:289. doi: 10.3389/fncel.2015.00289. eCollection 2015.

44.

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.

da Gama PD, Machado Ldos R, Livramento JA, Gomes HR, Adoni T, Morales Rde R, da Gama RA, da Gama DA, Lana-Peixoto MA, Fragoso YD, Callegaro D.

Biomed Res Int. 2015;2015:217961. doi: 10.1155/2015/217961. Epub 2015 Jul 29.

45.

Long-term morbidity after multivisceral resection for retroperitoneal sarcoma.

Callegaro D, Miceli R, Brunelli C, Colombo C, Sanfilippo R, Radaelli S, Casali PG, Caraceni A, Gronchi A, Fiore M.

Br J Surg. 2015 Aug;102(9):1079-87. doi: 10.1002/bjs.9829. Epub 2015 Jun 3.

PMID:
26041724
46.

Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger Than Age 18 Years.

Fragoso YD, Alves-Leon SV, Barreira AA, Callegaro D, Brito Ferreira ML, Finkelsztejn A, Gomes S, Magno Goncalves MV, Moraes Machado MI, Marques VD, Cunha Matta AP, Papais-Alvarenga RM, Apostolos Pereira SL, Tauil CB.

Pediatr Neurol. 2015 Aug;53(2):166-8. doi: 10.1016/j.pediatrneurol.2015.03.024. Epub 2015 Apr 2.

PMID:
26026897
47.

Pathologic yawning in neuromyelitis optica spectrum disorders.

Lana-Peixoto MA, Callegaro D, Talim N, Talim LE, Pereira SA, Campos GB; Brazilian Committee for Treatment and Research in Multiple Sclerosis.

Mult Scler Relat Disord. 2014 Jul;3(4):527-32. doi: 10.1016/j.msard.2014.04.002. Epub 2014 Apr 13.

PMID:
25877066
48.

Personalizing surgical margins in retroperitoneal sarcomas.

Callegaro D, Fiore M, Gronchi A.

Expert Rev Anticancer Ther. 2015 May;15(5):553-67. doi: 10.1586/14737140.2015.1028375. Epub 2015 Mar 23. Review.

PMID:
25797538
49.

Tongue forces and handgrip strength in normal individuals: association with swallowing.

Mendes AE, Nascimento L, Mansur LL, Callegaro D, Jacob Filho W.

Clinics (Sao Paulo). 2015 Jan;70(1):41-5. doi: 10.6061/clinics/2015(01)08.

50.

Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients.

Nali LH, Moraes L, Fink MC, Callegaro D, Romano CM, Oliveira AC.

Arq Neuropsiquiatr. 2014 Dec;72(12):960-5. doi: 10.1590/0004-282X20140142. Epub 2014 Dec 2.

Supplemental Content

Loading ...
Support Center